Issues related to COVID-19 vaccines. Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers. General discussions related to vaccine injury compensation programs and vaccine strain selection timelines.
2025 · 1st Quarter (Jan 1 - Mar 31)
NOVAVAX, INC.
Filed by CROSSROADS STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- CROSSROADS STRATEGIES, LLC
- Client
- NOVAVAX, INC.
- Filing UUID
- 7a728ddc-0224-4656-bf68-d2778b4a7da3
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4); H.Con.Res.14, FY2025 Budget Resolution; FY2025 Budget Reconciliation Process; all bio-pharmaceutical related provisions.
Literal federal measure citations: H.R.1968, H.Con.Res.14
Issues related to tariffs.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.